BONCRESA vs BONSITY

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. BONCRESA and BONSITY are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BONCRESA	BONSITY
Rating	70/100	70/100
Pharmacy pays	—	$540.38 /mL
Type	RX	RX
Active ingredient	DENOSUMAB-MOBZ	TERIPARATIDE
Manufacturer	Amneal	Alvogen
Dosage forms	Injectable	Injectable
Drug class	—	Parathyroid Hormone Analog
Boxed warning	Boxed warning	None
Treats	Postmenopausal Osteoporosis	Postmenopausal Osteoporosis, Hypoparathyroidism

boncresa bonsity

Rating

70/100

Pharmacy pays

—

$540.38 /mL

Type

Active ingredient

DENOSUMAB-MOBZ

TERIPARATIDE

Manufacturer

Amneal

Alvogen

Dosage forms

Injectable

Drug class

—

Parathyroid Hormone Analog

Boxed warning

None

Treats

Postmenopausal Osteoporosis

Postmenopausal Osteoporosis, Hypoparathyroidism

Frequently asked questions

Which is better-rated, Boncresa or Bonsity?

Boncresa and Bonsity are tied at 3.5 out of 5 by our independent rating.

What is the difference between Boncresa and Bonsity?

Boncresa contains Denosumab-Mobz, while Bonsity contains Teriparatide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.